XML 41 R35.htm IDEA: XBRL DOCUMENT v3.24.3
Acquisitions (Tables)
9 Months Ended
Sep. 30, 2024
Business Acquisition [Line Items]  
Schedule of Pro Forma Financial Statements

The unaudited pro forma financial information in the table below summarizes the combined GAAP revenue and net income (loss) results of the Company as though the acquisitions of ELITech and Chemspeed had been completed on January 1, 2023 (in millions):

 

 

Three months ended
September 30, 2024

 

 

Three months ended
September 30, 2023

 

 

 

Before Adjustments

 

 

Pro forma
Adjustments

 

 

After Adjustments

 

 

Before Adjustments

 

 

Pro forma
Adjustments

 

 

After Adjustments

 

Revenue

 

$

864.4

 

 

$

 

 

$

864.4

 

 

$

837.6

 

 

$

 

 

$

837.6

 

Net income (loss)

 

$

40.9

 

 

$

1.8

 

 

$

42.7

 

 

$

44.2

 

 

$

(19.0

)

 

$

25.2

 

 

 

 

Nine months ended
September 30, 2024

 

 

Nine months ended
September 30, 2023

 

 

 

Before Adjustments

 

 

Pro forma
Adjustments

 

 

After Adjustments

 

 

Before Adjustments

 

 

Pro forma
Adjustments

 

 

After Adjustments

 

Revenue

 

$

2,446.4

 

 

$

 

 

$

2,446.4

 

 

$

2,374.3

 

 

$

 

 

$

2,374.3

 

Net income (loss)

 

$

88.2

 

 

$

(15.7

)

 

$

72.5

 

 

$

68.8

 

 

$

(64.9

)

 

$

3.9

 

Pro forma adjustments that impact net income (loss)

The pro forma adjustments that impact net income (loss) include the following (in millions):

 

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Net (increase) decrease in amortization and depreciation expense associated with tangible and intangible assets

 

$

1.8

 

 

$

(9.0

)

 

$

(2.4

)

 

$

(34.9

)

Net increase in interest expense

 

 

 

 

 

(10.0

)

 

 

(13.3

)

 

 

(30.0

)

Total pro forma adjustments - net income (loss)

 

$

1.8

 

 

$

(19.0

)

 

$

(15.7

)

 

$

(64.9

)

2024 Acquisitions  
Business Acquisition [Line Items]  
Schedule of Components and Fair Value Allocation of the Consideration Transferred in Connection with Acquisitions The following table reflects the consideration transferred and the respective reportable segment for certain of the 2024 acquisitions (in millions):

 

 

 

NanoString Technologies, Inc.

 

ELITechGroup

 

Chemspeed Technologies AG

 

Other

 

Total

 

Segment

 

BSI NANO

 

BSI CALID

 

BSI BBIO

 

Various

 

 

 

Consideration Transferred:

 

 

 

 

 

 

 

 

 

 

 

Cash paid

 

$

392.6

 

$

951.9

 

$

175.4

 

$

107.1

 

$

1,627.0

 

Cash acquired

 

 

(0.5

)

 

(43.4

)

 

(0.6

)

 

(7.6

)

 

(52.1

)

Fair value of contingent consideration

 

 

 

 

 

 

 

 

13.4

 

 

13.4

 

Working capital and other closing adjustments

 

 

 

 

22.7

 

 

 

 

2.5

 

 

25.2

 

Total consideration transferred, net of cash acquired

 

$

392.1

 

$

931.2

 

$

174.8

 

$

115.4

 

$

1,613.5

 

Allocation of Consideration Transferred:

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

$

16.8

 

$

30.6

 

$

7.0

 

$

2.9

 

$

57.3

 

Inventories

 

 

51.5

 

 

31.6

 

 

48.7

 

 

29.4

 

 

161.2

 

Other current assets

 

 

8.9

 

 

15.7

 

 

1.4

 

 

1.1

 

 

27.1

 

Property, plant and equipment

 

 

31.0

 

 

36.2

 

 

1.8

 

 

0.9

 

 

69.9

 

Other assets

 

 

20.3

 

 

41.3

 

 

17.3

 

 

3.4

 

 

82.3

 

Intangible assets:

 

 

 

 

 

 

 

 

 

 

 

Technology

 

 

76.0

 

 

193.3

 

 

27.9

 

 

34.9

 

 

332.1

 

Customer relationships

 

 

71.0

 

 

236.3

 

 

51.5

 

 

5.7

 

 

364.5

 

Backlog

 

 

 

 

0.5

 

 

9.4

 

 

4.9

 

 

14.8

 

Trade name

 

 

20.0

 

 

12.3

 

 

4.8

 

 

2.2

 

 

39.3

 

Goodwill

 

 

181.8

 

 

500.1

 

 

123.5

 

 

68.6

 

 

874.0

 

Deferred taxes (net)

 

 

 

 

(99.8

)

 

(14.7

)

 

(2.5

)

 

(117.0

)

Liabilities assumed

 

 

(85.2

)

 

(66.9

)

 

(103.8

)

 

(36.1

)

 

(292.0

)

Total consideration allocated

 

$

392.1

 

$

931.2

 

$

174.8

 

$

115.4

 

$

1,613.5

 

Other 2024 Acquisitions  
Business Acquisition [Line Items]  
Schedule of Consideration Transferred and the Respective Reportable Segment for Each Acquisition

The following table reflects the consideration transferred and the respective reportable segment for the acquisition (in millions):

 

Name of Acquisition

 

Date Acquired

 

Segment

 

Total
Consideration, net of Cash Acquired

 

 

Cash
Consideration

 

Nanophoton Corporation

 

February 5, 2024

 

BSI CALID

 

 

13.3

 

 

 

10.8

 

Spectral Instruments Imaging LLC

 

February 1, 2024

 

BSI BBIO

 

 

29.3

 

 

 

29.0

 

Nion, LLC

 

January 2, 2024

 

BSI NANO

 

 

42.9

 

 

 

37.4

 

Tornado Spectral Systems, Inc.

 

January 1, 2024

 

BSI CALID

 

 

22.3

 

 

 

22.6

 

Other (In aggregate)

 

Various

 

Various

 

 

7.6

 

 

 

7.3

 

 

 

 

 

 

 

$

115.4

 

 

$

107.1

 

2023 Acquisitions  
Business Acquisition [Line Items]  
Schedule of Components and Fair Value Allocation of the Consideration Transferred in Connection with Acquisitions The following table reflects the consideration transferred and the reportable segment for these acquisitions (in millions):

 

 

 

Biognosys, AG

 

 

Zontal, Inc.

 

Segment

 

BSI CALID

 

 

BSI BioSpin

 

Consideration Transferred:

 

 

 

 

 

 

Cash paid

 

$

73.6

 

 

$

14.8

 

Cash acquired

 

 

(9.5

)

 

 

(0.3

)

Holdback

 

 

0.2

 

 

 

 

Fair value of hybrid financial instruments – founders

 

 

 

 

 

18.5

 

Fair value of redeemable noncontrolling interest – other shareholders

 

 

2.5

 

 

 

 

Fair value of contingent consideration

 

 

 

 

 

0.5

 

Total consideration transferred

 

$

66.8

 

 

$

33.5

 

Allocation of Consideration Transferred:

 

 

 

 

 

 

Accounts receivable

 

$

3.6

 

 

$

0.7

 

Inventories

 

 

0.4

 

 

 

 

Other current assets

 

 

0.9

 

 

 

0.3

 

Property, plant and equipment

 

 

8.0

 

 

 

 

Other assets

 

 

4.3

 

 

 

2.5

 

Intangible assets:

 

 

 

 

 

 

Technology

 

 

10.2

 

 

 

5.8

 

Customer relationships

 

 

13.8

 

 

 

4.0

 

Trade name

 

 

2.7

 

 

 

1.1

 

Backlog

 

 

0.8

 

 

 

0.2

 

Goodwill

 

 

47.5

 

 

 

25.9

 

Liabilities assumed

 

 

(25.4

)

(a)

 

(7.0

)

Total consideration allocated

 

$

66.8

 

 

$

33.5

 

(a) This amount includes assumed liability for employee awards of $6.3 million on the acquisition date and was settled in the period ended March 31, 2023.

Other 2023 Acquisitions  
Business Acquisition [Line Items]  
Schedule of Consideration Transferred and the Respective Reportable Segment for Each Acquisition The following table reflects the consideration transferred and the respective reportable segment for these acquisitions (in millions):

 

Name of Acquisition

 

Date Acquired

 

Segment

 

Total
Consideration

 

 

Cash
Consideration

 

Interherence GmbH

 

July 3, 2023

 

BSI CALID

 

$

17.3

 

 

$

3.9

 

Fasmatech Science SA

 

March 3, 2023

 

BSI CALID

 

 

10.3

 

 

 

8.4

 

Other (In aggregate)

 

Various

 

Various

 

 

16.2

 

 

 

11.2

 

 

 

 

 

 

 

$

43.8

 

 

$

23.5